NIFTY 50▲24,304.35
99.00 (0.41%)
SENSEX▲79,724.12
335.06 (0.42%)
NIFTY BANK▲51,673.90
198.55 (0.39%)
TATA MOTORS▲843.45
9.40 (1.13%)
SUZLON ENERGY▲68.14
1.19 (1.78%)
TATA STEEL▲149.75
1.19 (0.80%)
INDIAN RAILWAY FINANCE CORP▲158.11
2.15 (1.38%)
TATA POWER▲445.45
5.40 (1.23%)
RAIL VIKAS NIGAM▼470.95
-0.85 (-0.18%)
RELIANCE INDUSTRIES▲1,338.65
6.60 (0.50%)
VODAFONE IDEA▲8.45
0.33 (4.06%)
ZOMATO▲248.99
7.24 (2.99%)
RELIANCE POWER▲43.03
0.30 (0.70%)
INDIAN RENEWABLE ENERGY▲211.98
1.94 (0.92%)
ADANI POWER▲597.35
4.65 (0.78%)
YES BANK▲20.71
0.31 (1.52%)
STATE BANK OF INDIA▲821.20
1.00 (0.12%)
NHPC▲84.13
1.53 (1.85%)
HDFC BANK▲1,737.30
1.60 (0.09%)
OLA ELECTRIC MOBILITY LTD▲82.84
1.96 (2.42%)
JIO FIN SERVICES LTD▲326.20
3.90 (1.21%)
INDIAN OIL CORP▲144.99
2.37 (1.66%)
BHARAT ELECTRONICS▲288.65
3.75 (1.32%)
MRF▲1,23,379.95
855.50 (0.70%)
GTL INFRA▲2.18
0.10 (4.81%)
ADANI PORT & SEZ▲1,394.40
18.45 (1.34%)
JAIPRAKASH POWER VENTURES▲18.47
0.27 (1.48%)
ITC▲490.30
1.50 (0.31%)
GlaxoSmithKline Pharma Share Price
GLAXO
₹2,725.00+₹12.75 (0.47%) TodayLast updated on 01 Nov, 2024 | 18:59 IST
GlaxoSmithKline Pharma Share Price Chart
Please wait...
About GlaxoSmithKline Pharma
GlaxoSmithKline Pharma Financials
Market cap ₹45,947 Crs | Open ₹2,729.00 | Close ₹2,712.25 |
Circuit range ₹3,279.70 - ₹2,186.50 | Day range ₹2,721.10 - ₹2,742.95 | Year range ₹1,408.15 - ₹3,088.00 |
Volume 6,923 | Avg. traded ₹2,734.77 | Revenue (12m) ₹3,560 Crs |
GlaxoSmithKline PharmaGlaxoSmithKline Pharmaceuticals Limited is an India-based global healthcare company. The Company is engaged in the business of manufacturing, distributing and trading in pharmaceuticals. The Company has three product areas: vaccines, specialty and general medicine. Its general medicines business has a portfolio of medicines in anti-infectives, pain, vitamins medicine, nutritional, hormones, dermatologicals, respiratory and vaccines for adults and children. The Company's general medicine brands include Augmentin, Calpol, Ceftum, Eltroxin, CCM, Neosporin, Betnovate, Tenovate, T-bact and Physiogel. The Company's vaccine brands include Shingrix Herpes Zoster Vaccine, Infanrix Hexa, Synflorix, Boostrix, Havrix, Menveo, Fluarix Tetra and Varilrix. Its specialty medicine brands include Nucala, Seretide, and Trelegy Ellipta. Trelegy Ellipta, single inhaler triple therapy (SITT) for chronic obstructive pulmonary disease (COPD) patients. The Subsidiary of the Company is Biddle Sawyer Limited.
Glaxosmithkline Pharma Key indicators
52 week high ₹3,088.00 | 52 week low ₹1,408.15 | P/E ratio 68.49 |
P/B ratio 22.63 | ROE 32.96% | ROCE 45.85% |
Dividend yield 1.21% | Debt/Equity ratio | EPS 34.51 |
Learn more
Featured in
Investment checklist: (3/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Analyst ratings:
Analyst ratings:
50%
Hold
50%
Sell
0%
This analysis is based on the reviews of 4 experts in the last 7 days
GlaxoSmithKline Pharma Fundamentals
GlaxoSmithKline Pharma Financial Ratios
Operating profit margin27.4% | Net profit margin15.64% |
ROE32.96% | ROA17.73% |
ROCE45.85% |
Learn more
Glaxosmithkline Pharma Share Price history
Day | Open | Close | Change % |
---|---|---|---|
Fri, Nov 1 2024 | ₹2,729.00 | ₹2,733.10 | |
Thu, Oct 31 2024 | ₹2,670.00 | ₹2,712.25 | |
Wed, Oct 30 2024 | ₹2,676.00 | ₹2,674.25 | |
Tue, Oct 29 2024 | ₹2,642.00 | ₹2,629.65 | -0.57% |
Mon, Oct 28 2024 | ₹2,588.60 | ₹2,644.65 | |
Fri, Oct 25 2024 | ₹2,638.10 | ₹2,588.60 | -1.12% |
Thu, Oct 24 2024 | ₹2,635.35 | ₹2,618.05 | -0.47% |
Wed, Oct 23 2024 | ₹2,578.05 | ₹2,630.50 |
Events
Corporate actions
Dividend • ₹32/share
Ex date 31 May 2024
Dividend • ₹32/share
Ex date 30 Jun 2023
Dividend • ₹60/share
Ex date 07 Jul 2022
Dividend • ₹30/share
Ex date 07 Jul 2022
Learn more
More